BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36931174)

  • 1. Immunometabolomics provides a new perspective for studying systemic lupus erythematosus.
    Wu Y; Zhao M; Gong N; Zhang F; Chen W; Liu Y
    Int Immunopharmacol; 2023 May; 118():109946. PubMed ID: 36931174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic tests in systemic lupus erythematosus.
    Vasquez-Canizares N; Wahezi D; Putterman C
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):351-363. PubMed ID: 29224677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
    Thanou A; Jupe E; Purushothaman M; Niewold TB; Munroe ME
    J Autoimmun; 2021 May; 119():102615. PubMed ID: 33631651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for systemic lupus erythematosus - a focus on organ damage.
    Ding H; Shen Y; Hong SM; Xiang C; Shen N
    Expert Rev Clin Immunol; 2024; 20(1):39-58. PubMed ID: 37712757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention.
    Zhang L; Qing P; Yang H; Wu Y; Liu Y; Luo Y
    Front Immunol; 2021; 12():686501. PubMed ID: 34335588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy.
    Naithani U; Jain P; Sachan A; Khare P; Gabrani R
    Clin Exp Med; 2023 Dec; 23(8):4065-4077. PubMed ID: 37921874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.
    Huang X; Zhang Q; Zhang H; Lu Q
    Clin Rev Allergy Immunol; 2022 Dec; 63(3):311-329. PubMed ID: 35064901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus.
    Zhang Q; Yin X; Wang H; Wu X; Li X; Li Y; Zhang X; Fu C; Li H; Qiu Y
    Front Immunol; 2019; 10():976. PubMed ID: 31130958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus.
    Zhang Q; Li X; Yin X; Wang H; Fu C; Wang H; Li K; Li Y; Zhang X; Liang H; Li K; Li H; Qiu Y
    Rheumatology (Oxford); 2021 Feb; 60(2):598-606. PubMed ID: 32259244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising roles of combined therapy based on immune response and iron metabolism in systemic lupus erythematosus.
    Xing Z; Gao S; Zheng A; Tong C; Fang Y; Xiang Z; Chen S; Wang W; Hua C
    Int Immunopharmacol; 2024 Jun; 138():112481. PubMed ID: 38917527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus.
    Robinson GA; Wilkinson MGL; Wincup C
    Front Immunol; 2021; 12():806560. PubMed ID: 35154082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
    Chen KL; Krain RL; Werth VP
    F1000Res; 2019; 8():. PubMed ID: 30984372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy.
    Idborg H; Oke V
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?
    Schiffer L; Worthmann K; Haller H; Schiffer M
    Clin Exp Immunol; 2015 Jan; 179(1):85-9. PubMed ID: 25138065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever.
    Shin TH; Kim HA; Jung JY; Baek WY; Lee HS; Park HJ; Min J; Paik MJ; Lee G; Suh CH
    Metabolomics; 2017 Dec; 14(1):14. PubMed ID: 30830319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update.
    Romo-Tena J; Kaplan MJ
    Curr Opin Rheumatol; 2020 Nov; 32(6):562-571. PubMed ID: 32826478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress in systemic lupus erythematosus from 2021 to 2022].
    Li YZ; Wu XC
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):785-790. PubMed ID: 37668024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.